WallStSmart

Innovative Eyewear Inc. (LUCY)vsMedline Inc. Class A Common Stock (MDLN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medline Inc. Class A Common Stock generates 1188280% more annual revenue ($28.43B vs $2.39M). MDLN leads profitability with a 4.1% profit margin vs 0.0%. MDLN earns a higher WallStSmart Score of 52/100 (C-).

LUCY

Hold

38

out of 100

Grade: F

Growth: 4.3Profit: 2.5Value: 5.0Quality: 5.0

MDLN

Buy

52

out of 100

Grade: C-

Growth: 6.0Profit: 5.0Value: 8.3Quality: 7.8
Piotroski: 4/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for LUCY.

MDLNUndervalued (+32.7%)

Margin of Safety

+32.7%

Fair Value

$66.92

Current Price

$42.03

$24.89 discount

UndervaluedFair: $66.92Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LUCY2 strengths · Avg: 9.0/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Free Cash FlowQuality
$3.07B8/10

Generating 3.1B in free cash flow

MDLN0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

LUCY4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
1.6%4/10

1.6% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$5.89M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

MDLN4 concerns · Avg: 3.0/10
P/E RatioValuation
29.9x4/10

Moderate valuation

Return on EquityProfitability
6.5%3/10

ROE of 6.5% — below average capital efficiency

Profit MarginProfitability
4.1%3/10

4.1% margin — thin

Free Cash FlowQuality
$-113.00M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : LUCY

The strongest argument for LUCY centers on Price/Book, Free Cash Flow.

Bull Case : MDLN

Revenue growth of 14.8% demonstrates continued momentum.

Bear Case : LUCY

The primary concerns for LUCY are Revenue Growth, EPS Growth, Market Cap.

Bear Case : MDLN

The primary concerns for MDLN are P/E Ratio, Return on Equity, Profit Margin. Thin 4.1% margins leave little buffer for downturns.

Key Dynamics to Monitor

MDLN is growing revenue faster at 14.8% — sustainability is the question.

LUCY generates stronger free cash flow (3.1B), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MDLN scores higher overall (52/100 vs 38/100) and 14.8% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Innovative Eyewear Inc.

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Innovative Eyewear Inc. (LUCY) is at the forefront of the smart eyewear market, combining cutting-edge technology with contemporary design to serve a tech-oriented consumer base. The company's flagship Lucyd product line integrates audio capabilities and seamless connectivity, offering practical functionality while maintaining fashionable appeal. With an unwavering commitment to innovation and user experience enhancement, LUCY is poised to capitalize on the expanding demand for multifunctional wearables, positioning itself for substantial growth in the dynamic eyewear industry.

Medline Inc. Class A Common Stock

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. The company is headquartered in Northfield, Illinois.

Visit Website →

Want to dig deeper into these stocks?